e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatable traits: a step closer to the “holy grail” of asthma control?
William W. Busse
Source:
Eur Respir J, 55 (3) 2000002; 10.1183/13993003.00002-2020
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
William W. Busse. Treatable traits: a step closer to the “holy grail” of asthma control?. Eur Respir J, 55 (3) 2000002; 10.1183/13993003.00002-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The quest for the grail: multidimensional efforts for understanding and targeting severe asthma
Source: Eur Respir J 2015; 46: 1227-1231
Year: 2015
Pharmacogenetics and asthma: false hope or new dawn?
Source: Eur Respir J 2007; 29: 1239-1245
Year: 2007
Holy Grail: the journey towards disease modification in asthma
Source: Eur Respir Rev, 31 (163) 210183; 10.1183/16000617.0183-2021
Year: 2022
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017
Azithromycin in a bleomycin mouse model: finding the holy grail for pulmonary fibrosis?
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Asthma attacks in children are always preceded by poor asthma control: myth or maxim?
Source: Breathe, 16 (3) 200169; 10.1183/20734735.0169-2020
Year: 2020
COPD: Still a Cinderella?
Source: Eur Respir J 2003; 22: Suppl. 45, 67s
Year: 2003
Prognostic staging of acute pulmonary embolism: are we closer to the holy grail?
Source: Eur Respir J 2014; 44: 565-567
Year: 2014
Infection: friend or foe to the development of asthma?
Source: Eur Respir J 2001; 18: 744-747
Year: 2001
Control of asthma in real life: still a valuable goal?
Source: Eur Respir Rev 2015; 24: 361-369
Year: 2015
Patients' perception of peakflowmeters use in Ukraine: does it pose an issue for asthma control?
Source: Eur Respir J 2002; 20: Suppl. 38, 540s
Year: 2002
What’s new in the epidemiology of asthma?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021
Can " Beta-blockers" be useful to treat asthma?
Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Year: 2009
Pharmacological treatment optimisation for stable COPD: an endless story?
Source: Eur Respir J, 50 (4) 1701250; 10.1183/13993003.01250-2017
Year: 2017
Education makes people take their medication: myth or maxim?
Source: Breathe, 16 (1) 190338; 10.1183/20734735.0338-2019
Year: 2020
Asthma control test: how? And where?
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Treating asthma in developing countries: is this a question of money?
Source: Eur Respir J 2005; 26: Suppl. 49, 274s
Year: 2005
To tracheostomize or not to tracheostomize?
Source: Eur Respir J 2005; 26: Suppl. 49, 393s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept